Abstract
Rationale
Combined transcranial magnetic stimulation (TMS) and functional magnetic resonance imaging (fMRI) can be used to study anticonvulsant drugs. A previous study showed that lamotrigine (LTG) inhibited brain activation induced when TMS was applied over motor cortex, whereas it increased activation induced by TMS applied over prefrontal cortex.
Objectives
The present double-blind, placebo-controlled, crossover study in 30 healthy subjects again combined TMS and fMRI to test whether the effects seen previously with LTG would be confirmed and to compare these with a second anticonvulsant drug, valproic acid (VPA).
Results
Statistical parametric mapping analysis showed that both LTG and VPA, compared to placebo, inhibited TMS-induced activation of the motor cortex. In contrast, when TMS was applied over prefrontal cortex, LTG increased the activation of limbic regions, confirming previous results; VPA had no effect.
Conclusion
We conclude that LTG and VPA have similar inhibitory effects on motor circuits, but differing effects on the prefrontal corticolimbic system. The study demonstrates that a combination of TMS and fMRI techniques may be useful in the study of the effects of neuroactive drugs on specific brain circuits.
Similar content being viewed by others
References
Annett M (1970) A classification of hand preference by association analysis. Br J Psychol 61:303–321
Baudewig J, Siebner HR, Bestmann S, Tergau F, Tings T, Paulus W, Frahm J (2001) Functional MRI of cortical activations induced by transcranial magnetic stimulation (TMS). Neuroreport 12:3543–3548
Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J (2003) Subthreshold high-frequency TMS of human primary motor cortex modulates interconnected frontal motor areas as detected by interleaved fMRI-TMS. Neuroimage 20:1685–1696
Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J (2004) Functional MRI of the immediate impact of transcranial magnetic stimulation on cortical and subcortical motor circuits. Eur J Neurosci 19:1950–1962
Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J (2005) BOLD MRI responses to repetitive TMS over human dorsal premotor cortex. Neuroimage 28:22–29
Bohning DE, Shastri A, Wassermann EM, Ziemann U, Lorberbaum JP, Nahas Z, Lomarev MP, George MS (2000) BOLD-f MRI response to single-pulse transcranial magnetic stimulation (TMS). J Magn Reson Imaging 11:569–574
Bohning DE, Denslow S, Bohning PA, Walker JA, George MS (2003) A TMS coil positioning/holding system for MR image-guided TMS interleaved with fMRI. Clin Neurophysiol 114:2210–2219
Boroojerdi B, Battaglia F, Muellbacher W, Cohen LG (2001) Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin Neurophysiol 112:931–937
Borsook D, Becerra L, Hargreaves R (2006) A role for fMRI in optimizing CNS drug development. Nat Rev Drug Discov 5:411–424
Cho SS, Strafella AP (2009) rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One 4:e6725
Czapinski P, Blaszczyk B, Czuczwar SJ (2005) Mechanisms of action of antiepileptic drugs. Curr Top Med Chem 5:3–14
SR FMB, Gibbon M, Williams JBW (1995) Structured clinical interview for DSM-IV I disorder. American Psychiatric Association, Washington
Friston KJ, Nahmias C, Shceffel A, Firnau G, Upton A (1994) Assisting the significance of focal activations using their spatial extent. Hum Brain Mapp 1:214–220
Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD (1996) Detecting activations in PET and fMRI: levels of inference and power. Neuroimage 4:223–235
Gajwani P, Forsthoff A, Muzina D, Amann B, Gao K, Elhaj O, Calabrese JR, Grunze H (2005) Antiepileptic drugs in mood-disordered patients. Epilepsia 46(Suppl 4):38–44
George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, Hallett M, Post RM (1995) Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 6:1853–1856
Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R (2004) A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 65:432–441
Haldane M, Jogia J, Cobb A, Kozuch E, Kumari V, Frangou S (2008) Changes in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with Lamotrigine monotherapy. Eur Neuropsychopharmacol 18:48–54
Herwig U, Padberg F, Unger J, Spitzer M, Schonfeldt-Lecuona C (2001) Transcranial magnetic stimulation in therapy studies: examination of the reliability of “standard” coil positioning by neuronavigation. Biol Psychiatry 50:58–61
Hurley S (2002) Lamotrigine update and its use in mood disorders. Ann Pharmacother 36:860–873
Ketter TA, Calabrese JR (2002) Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J Clin Psychiatry 63:146–151
Ketter TA, Manji HK, Post RM (2003) Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. J Clin Psychopharmacol 23:484–495
Koski L, Paus T (2000) Functional connectivity of the anterior cingulate cortex within the human frontal lobe: a brain-mapping meta-analysis. Exp Brain Res 133:55–65
Large CH, Daniel ED, Li X, George MS (2009) Neural network dysfunction in bipolar depression: clues from the efficacy of lamotrigine. Biochem Soc Trans 37:1080–1084
Li X, Nahas Z, Kozel FA, Anderson B, Bohning DE, George MS (2004a) Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biol Psychiatry 55:882–890
Li X, Teneback CC, Nahas Z, Kozel FA, Large C, Cohn J, Bohning DE, George MS (2004b) Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology 29:1395–1407
Li X, Ricci R, Large CH, Anderson B, Nahas Z, George MS (2009) Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability. J Neural Transm 116:423–429
Loscher W (1998) New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 342:1–13
Loscher WN, Nordlund MM (2002) Central fatigue and motor cortical excitability during repeated shortening and lengthening actions. Muscle Nerve 25:864–872
Manganotti P, Bongiovanni LG, Zanette G, Turazzini M, Fiaschi A (1999) Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation. Epilepsia 40:316–321
Margulies DS, Kelly AM, Uddin LQ, Biswal BB, Castellanos FX, Milham MP (2007) Mapping the functional connectivity of anterior cingulate cortex. Neuroimage 37:579–588
Messenheimer JA (1995) Lamotrigine. Epilepsia 36(Suppl 2):S87–S94
Nahas Z, Lomarev M, Roberts DR, Shastri A, Lorberbaum JP, Teneback C, McConnell K, Vincent DJ, Li X, George MS, Bohning DE (2001) Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI. Biol Psychiatry JID-0213264 50:712–720
Paulus W, Classen J, Cohen LG, Large CH, Di Lazzaro V, Nitsche M, Pascual-Leone A, Rothwell JC, Ziemann U (2008) State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimulation 2:151–163
Rogawski MA, Loscher W (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5:553–564
Shastri A, George MS, Bohning DE (1999) Performance of a system for interleaving transcranial magnetic stimulation with steady-state magnetic resonance imaging. Electroencephalogr Clin Neurophysiol Suppl 51:55–64
Tracey I (2001) Prospects for human pharmacological functional magnetic resonance imaging (phMRI). J Clin Pharmacol Suppl:21S–28S
Wise RG, Tracey I (2006) The role of fMRI in drug discovery. J Magn Reson Imaging 23:862–876
Xie X, Hagan RM (1998) Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology 38:119–130
Xie X, Lancaster B, Peakman T, Garthwaite J (1995) Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na + channels and with native Na + channels in rat hippocampal neurones. Pflugers Arch 430:437–446
Zaccara G, Messori A, Moroni F (1988) Clinical pharmacokinetics of valproic acid—1988. Clin Pharmacokinet 15:367–389
Ziemann U (2004) TMS and drugs. Clin Neurophysiol 115:1717–1729
Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W (1996) Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 40:367–378
Ziemann U, Steinhoff BJ, Tergau F, Paulus W (1998) Transcranial magnetic stimulation: its current role in epilepsy research. Epilepsy Res 30:11–30
Ziemann U, Tam A, Butefisch C, Cohen LG (2002) Dual modulating effects of amphetamine on neuronal excitability and stimulation-induced plasticity in human motor cortex. Clin Neurophysiol 113:1308–1315
Acknowledgments
This study was funded primarily by an unrestricted research grant from GlaxoSmithKline to Dr. George, as well as from Center for Advanced Imaging Research and Brain Stimulation Laboratory infrastructure and resources. CHL is a full-time employee of GlaxoSmithKline S.p.A. None of the other authors has equity or financial conflicts. Drs. Li and George had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Table S1
Comparisons of drugs of TMS in active regions during 100% MT-TMS and voluntary movement over motor cortex. Voluntary movement of the thumb caused a BOLD response in primary motor cortex (M1), premotor cortex (PMd), supplemental motor area (SMA), nucleus caudatus, and thalamus. Analyzing the effects of drug treatment compared to placebo on the BOLD response induced by voluntary thumb movement, a significantly smaller response was observed in the caudate nucleus after treatment with either LTG or VPA. However, comparing LTG and VPA, the BOLD response to voluntary thumb movement in inferior parietal, putamen, and caudate was reduced to a greater extent by VPA, whereas LTG reduced the response in SMA to a greater extent. A two-way ANOVA within SPM showed a significant main effect of TMS intensity (F = 11.29, df = 1, 144). TMS intensity-related changes were observed in paracentral lobule, postcentral gyrus/precentral gyrus, and SMA. Considering stimulus intensity, on the placebo day, motor cortex TMS at 120% RMT caused more activation than 100% RMT in M1 and SMA. However, following treatment with either LTG or VPA, no significant difference in motor cortex TMS-induced BOLD response was observed comparing 100% RMT with 120% RMT in any brain region (XLS 26 kb)
Table S2
Comparisons of drugs of TMS in active regions during 100% MT-TMS and voluntary movement over prefrontal cortex. A two-way ANOVA indicated a significant main effect of TMS intensity (F = 11.38; df = 1, 120). TMS intensity-related changes were observed in anterior cingulate cortex and superior medial frontal cortex. With respect to stimulus intensity, on the placebo day, TMS at 120% RMT over prefrontal cortex caused more activation than TMS at 100% RMT in anterior cingulate cortex. Following treatment with LTG, TMS at 120% RMT caused more activation than 100% RMT in superior medial frontal cortex. Finally, following treatment with VPA, there was no significant difference in activation caused by TMS at 100% RMT and TMS at 120% RMT in any brain region (XLS 25 kb)
Rights and permissions
About this article
Cite this article
Li, X., Ricci, R., Large, C.H. et al. Interleaved transcranial magnetic stimulation and fMRI suggests that lamotrigine and valproic acid have different effects on corticolimbic activity. Psychopharmacology 209, 233–244 (2010). https://doi.org/10.1007/s00213-010-1786-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-010-1786-y